2 Penny Stocks at Opposite Ends of the Nasdaq Today

Achieve Life Sciences reported positive data for its smoking cessation drug

Managing Editor
Sep 27, 2018 at 10:10 AM
facebook twitter linkedin


Geron Corporation (NASDAQ:GERN) stock is down 68.7% to trade at $1.95 -- fresh off a four-year low of $1.50, and the worst stock on the Nasdaq this morning -- after the company said Johnson & Johnson (JNJ) division Janssen will terminate its collaboration for imetelstat, a blood disorder treatment, even as a recent job posting suggested otherwise. The drug program will now be developed by Geron independently, which prompted the firm to raise its 2018 operating expenses outlook by $7 million to $37 million.

Although the stock quickly found itself on the short-sale restricted (SSR) list this morning, short sellers are likely cheering today's collapse. Short interest increased by 6% in the last two reporting periods to 63.43 million shares -- the highest in at least 16 years. This represents nearly 40% of GERN's total available float, and 5.8 times the average daily trading volume.  

Achieve Life Sciences Inc (NASDAQ:ACHV) stock, on the other hand, is up 58.8% to trade at $4.34 this morning -- one of the top stocks on the Nasdaq so far. Driving ACHV higher is news that a new formulation for the company's smoking cessation treatment, cytisine, was successful in a recent study.

This is shaping up to be ACHV's best day since late 2008. Today's rally has the shares slicing through their 40-day moving average, a trendline that kept a tight lid on breakouts in the past four months. Nevertheless, the shares remain 81% lower year-over-year, and hit a record low of $2.40 on Sept. 18.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners